InsidersTradesSigma
Follow the BIOMAXIMA S.A. stock price and the full directors' dealings record of the company, a listed equity based in Poland. Shares are quoted on the PL market, under the oversight of KNF. Market capitalisation: €42.6m. The latest transaction was disclosed on 13 August 2026 (Purchase). Among the most active insiders: Asakura sp. z o.o.. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
BIOMAXIMA S.A. is a Polish company specializing in the development and production of medical diagnostic reagents. It primarily operates on the Warsaw stock market.